{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:42:30Z","timestamp":1768077750614,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":525,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/mt.2015.17","type":"journal-article","created":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T07:14:32Z","timestamp":1423206872000},"page":"964-973","source":"Crossref","is-referenced-by-count":12,"title":["T-cell Subsets in Peripheral Blood and Tumors of Patients Treated With Oncolytic Adenoviruses"],"prefix":"10.1016","volume":"23","author":[{"given":"Taipale","family":"Kristian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liikanen","family":"Ilkka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhila","family":"Juuso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karioja-Kallio","family":"Aila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oksanen","family":"Minna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turkki","family":"Riku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linder","family":"Nina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lundin","family":"Johan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ristim\u00e4ki","family":"Ari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanerva","family":"Anna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koski","family":"Anniina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joensuu","family":"Timo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e4h\u00e4-Koskela","family":"Markus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemminki","family":"Akseli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.17_bib1","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1038\/mt.2015.17_bib2","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1056\/NEJMra072739","article-title":"Cancer immunology","volume":"358","author":"Finn","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2015.17_bib3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00011-013-0645-9","article-title":"Immune system: a double-edged sword in cancer","volume":"62","author":"Lakshmi Narendra","year":"2013","journal-title":"Inflamm Res"},{"key":"10.1038\/mt.2015.17_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.immuni.2013.07.005","article-title":"Deciphering and reversing tumor immune suppression","volume":"39","author":"Motz","year":"2013","journal-title":"Immunity"},{"key":"10.1038\/mt.2015.17_bib5","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1158\/0008-5472.CAN-10-1322","article-title":"CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes","volume":"70","author":"Bos","year":"2010","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.17_bib6","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","article-title":"Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer","volume":"71","author":"Tosolini","year":"2011","journal-title":"Cancer Res"},{"issue":"2 Pt 2","key":"10.1038\/mt.2015.17_bib7","doi-asserted-by":"crossref","first-page":"727s","DOI":"10.1158\/1078-0432.CCR-06-1924","article-title":"Reversal of tumor-mediated immunosuppression","volume":"13","author":"Vieweg","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2015.17_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/mt.2015.17_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cellimm.2012.08.004","article-title":"T cell subsets and colorectal cancer: discerning the good from the bad","volume":"279","author":"Scurr","year":"2012","journal-title":"Cell Immunol"},{"key":"10.1038\/mt.2015.17_bib10","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"10.1038\/mt.2015.17_bib11","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/cncr.23712","article-title":"Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer","volume":"113","author":"Kawai","year":"2008","journal-title":"Cancer"},{"key":"10.1038\/mt.2015.17_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/onc.2009.416","article-title":"Immune infiltration in human tumors: a prognostic factor that should not be ignored","volume":"29","author":"Pag\u00e8s","year":"2010","journal-title":"Oncogene"},{"key":"10.1038\/mt.2015.17_bib13","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy","volume":"17","author":"Rosenberg","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2015.17_bib14","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1016\/j.vaccine.2009.03.074","article-title":"In situ adenovirus vaccination engages T effector cells against cancer","volume":"27","author":"Tuve","year":"2009","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.17_bib15","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.2174\/138920112800958913","article-title":"Oncolytic viruses for induction of anti-tumor immunity","volume":"13","author":"Tong","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1038\/mt.2015.17_bib16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.mt.6300031","article-title":"Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors","volume":"15","author":"Cerullo","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.17_bib17","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1158\/0008-5472.CAN-11-2975","article-title":"Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus","volume":"72","author":"Diaconu","year":"2012","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.17_bib18","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1158\/0008-5472.CAN-09-3567","article-title":"Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients","volume":"70","author":"Cerullo","year":"2010","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.17_bib19","first-page":"39","article-title":"Patients treated with oncolytic adenovirus Ad5\/3-hTERT-E2FGMCSF induce immunological responses against the tumor","author":"Hemminki","year":"2014","journal-title":"CIMT 2014 Abstracts"},{"key":"10.1038\/mt.2015.17_bib20","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1158\/1078-0432.CCR-12-2546","article-title":"Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus","volume":"19","author":"Kanerva","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2015.17_bib21","first-page":"67","article-title":"Characterization of tumor-infiltrating lymphocytes following intratumoral administration of a chimeric adenovirus Ad5\/3-D24-GMCSF (ONCOS-102) for refractory cancer patients with solid tumors","author":"Pesonen","year":"2014","journal-title":"CIMT 2014 Abstracts"},{"key":"10.1038\/mt.2015.17_bib22","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/mt.2013.51","article-title":"Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients","volume":"21","author":"Liikanen","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.17_bib23","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/mt.2011.113","article-title":"Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus","volume":"19","author":"Cerullo","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.17_bib24","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/mt.2010.161","article-title":"Treatment of cancer patients with a serotype 5\/3 chimeric oncolytic adenovirus expressing GMCSF","volume":"18","author":"Koski","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.17_bib25","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1158\/0008-5472.CAN-11-3001","article-title":"Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients","volume":"72","author":"Pesonen","year":"2012","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.17_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc2293","article-title":"Survivin, cancer networks and pathway-directed drug discovery","volume":"8","author":"Altieri","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/mt.2015.17_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrclinonc.2010.223","article-title":"Immune parameters affecting the efficacy of chemotherapeutic regimens","volume":"8","author":"Zitvogel","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1038\/mt.2015.17_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/cdd.2013.72","article-title":"Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists","volume":"21","author":"Yamazaki","year":"2014","journal-title":"Cell Death Differ"},{"key":"10.1038\/mt.2015.17_bib29","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/gt.2011.37","article-title":"Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12R\u03b22 or IL-18R\u03b1","volume":"18","author":"Choi","year":"2011","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.17_bib30","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1245\/s10434-009-0809-6","article-title":"Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma","volume":"17","author":"Kaufman","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/mt.2015.17_bib31","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/mt.2012.137","article-title":"An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearance","volume":"20","author":"Cerullo","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.17_bib32","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1128\/JVI.00104-08","article-title":"Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes","volume":"82","author":"Pelka","year":"2008","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.17_bib33","first-page":"764","article-title":"Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8+ T cells","volume":"40","author":"Xu","year":"2012","journal-title":"Int J Oncol"},{"key":"10.1038\/mt.2015.17_bib34","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.4049\/jimmunol.1203539","article-title":"Profound impairment of adaptive immune responses by alkylating chemotherapy","volume":"190","author":"Litterman","year":"2013","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.17_bib35","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1158\/0008-5472.CAN-11-1466","article-title":"Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control","volume":"71","author":"Hong","year":"2011","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.17_bib36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/neuonc\/noq204","article-title":"Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme","volume":"13","author":"Fadul","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1038\/mt.2015.17_bib37","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1200\/JCO.2009.26.7609","article-title":"Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates","volume":"28","author":"Brahmer","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2015.17_bib38","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1089\/hum.2013.123","article-title":"[(18)F]-fluorodeoxyglucose positron emission tomography and computed tomography in response evaluation of oncolytic adenovirus treatments of patients with advanced cancer","volume":"24","author":"Koski","year":"2013","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.17_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00262-011-1181-5","article-title":"Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells","volume":"61","author":"Hurwitz","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1038\/mt.2015.17_bib40","doi-asserted-by":"crossref","first-page":"430394","DOI":"10.1155\/2011\/430394","article-title":"The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance","volume":"2011","author":"Janikashvili","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1038\/mt.2015.17_bib41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00262-011-1161-9","article-title":"Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients","volume":"61","author":"Filipazzi","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1038\/mt.2015.17_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jclinpath-2011-200355","article-title":"Tumour-infiltrating macrophages and clinical outcome in breast cancer","volume":"65","author":"Mahmoud","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1038\/mt.2015.17_bib43","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.juro.2008.11.090","article-title":"Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Guerin instillation","volume":"181","author":"Takayama","year":"2009","journal-title":"J Urol"},{"key":"10.1038\/mt.2015.17_bib44","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2217\/imt.13.102","article-title":"Targeting tumor-infiltrating macrophages to combat cancer","volume":"5","author":"Panni","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1038\/mt.2015.17_bib45","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1158\/1078-0432.CCR-13-1471","article-title":"Oncolytic virotherapy trials\u2013letter","volume":"19","author":"Hemminki","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2015.17_bib46","first-page":"862925","article-title":"Oncolytic immunotherapy: where are we clinically?","volume":"2014","author":"Hemminki","year":"2014","journal-title":"Scientifica (Cairo)"},{"key":"10.1038\/mt.2015.17_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/mt.2011.230","article-title":"Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancer","volume":"20","author":"Koski","year":"2012","journal-title":"Mol Ther"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T08:24:29Z","timestamp":1537863869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616301204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1525001616301204"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.17","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}